MAZE (Maze Therapeutics) Insider Ownership: 1.10 % (As of Sep. 21, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

MAZE Maze Therapeutics Inc MAZE
16 GF Score
Price $22.30
! 3 Warning Signs
View Full Analysis

What is Maze Therapeutics Insider Ownership?

Maze Therapeutics MAZE -0.98% 16 Insider Ownership is 1.10 % as of Sep. 21, 2026. GuruFocus rates MAZE with a GF Score™ of 16/100. The stock has 3 warning signs investors should review.

Insider ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Maze Therapeutics's insider ownership is 1.10%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Maze Therapeutics's Institutional Ownership is 110.61%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Maze Therapeutics's Float Percentage Of Total Shares Outstanding is 88.81%.

Maze Therapeutics Insider Ownership Historical Data

* Premium members only.

The historical data trend for Maze Therapeutics's Insider Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Maze Therapeutics Insider Ownership Chart

Maze Therapeutics Historical Data

The historical data trend for Maze Therapeutics can be seen below:

2025-08-31 2025-09-30 2025-10-31 2025-11-30 2026-01-31 2026-02-28 2026-05-31 2026-06-30 2026-07-31 2026-08-31
Insider Ownership 1.46 1.41 1.23 1.23 1.23 1.23 1.22 1.10 1.10 1.10
MAZE
16GF Score
Maze Therapeutics Inc MAZE
Insider Ownership is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Maze Therapeutics Insider Ownership Calculation

The percentage of shares that are owned by company insiders relative to the total shares outstanding.

Frequently Asked Questions Learn more about Insider Ownership →
What does a Insider Ownership of 1.10 % mean?
Maze Therapeutics (MAZE) has a Insider Ownership of 1.10 % as of Sep. 21, 2026. Insider ownership equals the percent of shares owned by company insiders relative to total shares. View historical data on Maze Therapeutics and its competitors.
Is Maze Therapeutics' Insider Ownership too high?
Maze Therapeutics' current Insider Ownership is 1.10 %. Overall, Maze Therapeutics has a GF Score™ of 16/100, reflecting its overall financial health beyond just this single metric.
How does Maze Therapeutics' Insider Ownership compare to NVAX and SLBT?
Maze Therapeutics' Insider Ownership of 1.10 % can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Insider Ownership for a Biotechnology company?
A good Insider Ownership depends on the Biotechnology industry context. However, Insider Ownership should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Insider Ownership mean?
A high Insider Ownership can signal that a stock is expensive relative to its fundamentals. Insider ownership equals the percent of shares owned by company insiders relative to total shares. View historical data on Maze Therapeutics and its competitors. Maze Therapeutics's current Insider Ownership is 1.10 %. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Maze Therapeutics stock overvalued right now?
Maze Therapeutics (MAZE) has a current Insider Ownership of 1.10 %. The current Insider Ownership is 1.10 %. Maze Therapeutics' overall GF Score™ is 16/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Insider Ownership calculated?
Insider Ownership is calculated from a company's financial statements. For Maze Therapeutics (MAZE), the current Insider Ownership is 1.10 % as of Sep. 21, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Maze Therapeutics Business Description

Address 171 Oyster Point boulevard, Suite 300, South San Francisco, CA, USA, 94080
Maze Therapeutics Inc is a clinical-stage biopharmaceutical company harnessing the power of human genetics to develop novel, small-molecule precision medicines for patients living with renal, cardiovascular, and related metabolic, or CVRM, diseases, including obesity. The company is advancing a pipeline using its Compass platform, which allows the company to identify and characterize genetic variants in disease and then link those variants to the biological pathways that drive disease in specific patient groups through a process it refers to as variant functionalization. It is currently advancing two programs, MZE829 and MZE782, each of which represents a novel precision medicine-based approach for chronic kidney disease, or CKD.
16GF Score

Get the complete analysis for MAZE

Insider Ownership is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$22.30
Price